Parameters for Irreversible Inactivation of Monoamine Oxidase.

Area of Science:

• Biochemistry
• Neuroscience
• Medicinal Chemistry

Background:

• Irreversible inhibitors of monoamine oxidases (MAO) are vital for managing neurotransmitter metabolism in depression and neurodegenerative diseases.
• Established irreversible inhibitors like hydrazines, cyclopropylamines, and propargylamines form covalent adducts with the flavin cofactor after MAO oxidation.

Purpose of the Study:

• To update kinetic parameters for established irreversible MAO inhibitors interacting with human MAO-A and MAO-B.
• To analyze the essential structural and chemical features required for designing novel neuroprotective compounds.

Main Methods:

• Kinetic parameter determination (K_i values) for MAO-A and MAO-B.
• Molecular modeling and analysis of non-covalent interactions.
• Visible spectroscopy and molecular dynamics simulations to investigate inhibitor inactivation.

Main Results:

• MAO-A selectivity is dictated by initial reversible binding, with specific H-bond donor, hydrophobic-aromatic features, and an ionizable amine being critical.
• Aryl halogenation enhances hydrophobic interactions, stabilizing ligands for efficient transformation.
• Optimal orientation of the inhibitor and the resulting allenyl imine product towards the FAD cofactor is essential for covalent adduct formation and MAO inactivation.

Conclusions:

• Understanding the precise non-covalent and covalent interactions is key to designing potent and selective irreversible MAO inhibitors.
• This research provides a foundation for developing new therapeutic agents targeting MAO for neurodegenerative diseases.